Troponin and other cardiac markers: Role in management of acute coronary syndromes

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 3, 1999, Pages 436-443

  Ohman, E M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Acute coronary syndromes; Prognosis; Risk stratification; Troponins

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; TROPONIN;

CONFERENCE PAPER; ELECTROCARDIOGRAM; EMERGENCY WARD; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT;

EID: 0033066385     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb00740.x     Document Type: Conference Paper

References (56)

1. 1. Hedges JR, Young GP, Henkel GF et al. Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction. Ann Emerg Med 1992; 21: 1445-50.
2. 2. Gibler WB, Runyon JP, Levy RC et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med 1995; 25: 1-8.
3. 3. Gibler WB, Sayre MR, Levy RC et al. Serial 12-lead electrocardiographic monitoring in patients presenting to the emergency department with chest pain. J Electrocardiol 1994; 26: S238-43.
4. 4. van Lente F, McErlean ES, DeLuca S et al. Utility of a rapid bedside troponin T compared to quantitative troponin T in patients with suspected coronary syndrome. Circulation 1997; 96 (Suppl. I): I-215.
5. 5. Hamm CW, Goldman BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing of cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648-53.
6. 6. Ohman EM, Armstrong PW, Weaver WD et al. Prognostic value of whole-blood troponin T testing in patients with acute myocardial infarction in the GUSTO-III trial. Circulation 1997; 96 (Suppl. I): I-216.
7. 7. Hoekstra JW, Hedges JR, Gibler WB, Rubison M, Christensen RA. Emergency Department CK-MB: a predictor of ischemic complications. Acad Emerg Med 1994; 1: 17-28.
8. 8. Young GP, Green TR. The role of a single ECG, creatine kinase and CKMB in diagnosing patients with acute chest pain. Am J Emerg Med 1993; 11: 444-9.
9. 9. Downie AC, Frost PG, Fielden P, Joshi D, Dancy CM. Bedside measurement of creatine kinase to guide thrombolysis on the coronary care unit. Lancet 1993; 341: 452-4.
10. 10. Parvin CA, Lo SF, Deuser SM, Weaver LG, Lewis LM, Scott MG. Impact of point-of-care testing on patients' length of stay in a large emergency department. Clin Chem 1996; 42: 711-7.
11. 11. Puleo PR, Meyer D, Wathen C et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331: 562-608.
12. 12. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750-63.
13. 13. Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in humans. Circ Res 1991; 69: 1226-33.
14. 14. Saggin L, Gorza L, Ausoni S, Schiaffino S. Cardiac troponin T in developing, regenerating and denervating rat skeletal muscle. Development 1990; 110: 547-54.
15. 15. Bodor GS, Survant L, Voss EM, Smith S, Porterfield D, Apple FS. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 1997; 43: 476-84.
16. 16. Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci 1992; 29: 31-57.
17. 17. Adams JE III, Bodor GS, Davita-Roman VG et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88: 101-6.
18. 18. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992; 38: 2203-14.
19. 19. Wu AHB, Valdes R Jr, Apple FS et al. Cardiac troponin T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994; 40: 900-7.
20. 20. Christenson RH, Duh SH, Newby LK et al., for the GUSTO-IIa Investigators. Cardiac troponin T and cardiac troponin I: relative value in short-term risk stratification of patients with acute coronary syndromes. Clin Chem 1998; 44: 494-50.
21. 21. Newby LK, Ohman EM, Granger BB et al. Use of diagnostic tools in a chest pain unit: value of troponin T testing. J Am Coll Cardiol 1997; 29: 211A.
22. 22. Wu AHB, Feng YJ, Contois JH, Pervaiz S. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction. J Clin Lab Science 1996; 26: 291.
23. 23. Bhayana V, Gougoulias T, Cohoe S, Henderson AR. Discordance between results for serum troponin T and troponin I in renal disease. Clin Chem 1995; 14: 312-7.
24. 24. Li D, Keffer J, Corry K et al. Nonspecific elevation of troponin T levels in patients with chronic renal failure. Clin Biochem 1995; 28: 474-7.
25. 25. Frankel WL, Herold DA, Zeigler TW, Fitzgerald RL. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol 1996; 106: 118-23.
26. 26. Croitoru M, Taegtmeyer H. Spurious rises in troponin T in end-stage renal disease. Lancet 1995; 346: 974.
27. 27. Hossein-Nia M, Nisbet J, Merton GK, Holt DW. Spurious rises of cardiac troponin T. Lancet 1995; 346: 1558.
28. 28. Escalon JC, Wong SS. False-positive cardiac troponin T levels in chronic hemodialysis patients. Cardiology 1996; 87: 268-9.
29. 29. Hafner G, Thome-Kromer B, Schaube J et al. Cardiac troponins in serum in chronic renal failure. Clin Chem 1994; 40: 1790-1.
30. 30. Katus HA, Haller C, Muller-Bardorff M et al. Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis. Clin Chem 1995; 41: 1201-3.
31. 31. Li D, Jailal I, Keffer J. Greater frequency of increased cardiac troponin T than cardiac troponin I in patients with chronic renal failure. Clin Chem 1996; 42: 114-5.
32. 32. Braun SL, Baum H, Neumeier D, Vogt W. Troponin T and troponin I after coronary artery bypass grafting: discordant results in patients with renal failure. Clin Chem 1996; 42: 781-3.
33. 33. Haller C, Zehelein J, Remppis A et al. Cardiac troponin T in patients with renal failure. J Am Coll Cardiol 1997; 29: 234A.
34. 34. Apple FS, Sharkey SW, Hoeft P et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcome analysis. Am J Kidney Dis 1997; 29: 399-403.
35. 35. Rude RE, Poole WK, Muller JE et al Electrocardiographic and clinical criteria for the recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol 1983; 52: 936-42.
36. 36. Yusuf S, Pearson M, Sterry H et al. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. Eur Heart J 1984; 5: 690-6.
37. 37. Sobel BE, Bresnehan GF, Shell WE, Yoder RD. Estimation of infarct size in man and its relation to prognosis. Circulation 1972; 46: 640-8.
38. 38. Sobel BE, Roberts R, Larson KB. Estimation of infarct size from serum MB creatine phosphokinase activity: applications and limitations. Am J Cardiol 1976; 37: 474-85.
39. 39. Thompson PL, Fletcher EE, Katavatis V. Enzymatic indices of myocardial necrosis, influence on short-and long-term prognosis after myocardial infarction. Circulation 1979; 59: 113-9.
40. 40. Grande P, Hansen BF, Christianson C, Naestoft J. Estimation of acute myocardial infarct size in man by serum CK-MB measurements. Circulation 1982; 65: 756-64.
41. 41. Christenson RH, O'Hanesian MA, Newby LK et al., for the TAMI Study Group. Relation of area under the CK-MB release curve and clinical outcomes in myocardial infarction patients treated with thrombolytic therapy. Eur Heart J 1995; 16 (Suppl.): 75.
42. 42. Baardman T, Hermens WT, Lenderink T et al. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. Eur Heart J 1996; 17: 237-46.
43. 43. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
44. 44. Simes RJ, Topol EJ, Holmes DR et al., for the GUSTO-I Investigators. Link between angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation 1995; 91: 1923-8.
45. 45. Ohman EM, Armstrong PW, Christenson RH et al., for the GUSTO -IIa Investigators. Cardiac troponin T for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333-41.
46. 46. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996; 94: 1291-7.
47. 47. Woodlief LH, Lee KL, Califf RM, for the GUSTO IIa Investigators. Validation of a mortality model in 1384 patients with acute myocardial infarction. Circulation 1995; 92 (Suppl. I): I-776.
48. 48. Calvin JE, Klein LW, Van den Berg BJ et al. Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA 1995; 273: 136-41.
49. 49. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651-7.
50. 50. Antman EM, Tanasijevic MJ, Thompson B et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342-9.
51. 51. Christenson RH, Armstrong PW, O'Hanesian MA et al., for the GUSTO-IIa Investigators. The value of serial troponin T measurement for risk stratification in patients with acute coronary syndromes. Circulation 1995; 92 (Suppl. I): I-663.
52. 52. Newby LK, Christenson RH, Peck S et al. Risk stratification by troponin T occurs within the first 30 days of acute coronary syndromes: one year results from the GUSTO-IIa troponin T substudy. Circulation 1997; 96 (Suppl. I): I-215.
53. 53. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. Br Med J 1996; 313: 262-4.
54. 54. Lindahl B, Venge P, Wallentin L, for the Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997; 29: 43-8.
55. 55. Hamm CW, Heeschen C, Goldmann BU, Bar Nathan E, Simoons ML, for the CAPTURE Investigators. Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina. J Am Coll Cardiol 1998; 31: 185A.
56. 56. Luscher MS, Thygeson K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997; 96: 2578-85.